1. Koshihara Y, Hoshi K, Okawara R, Ishibashi H, Yamamoto S. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol. 2003. 176(3):339–348.
Article
2. Orimo H, Shiraki M, Tomita A, Morii H, Fujita T, Ohata M. Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: a double-blind placebo-controlled study. J Bone Miner Metab. 1998. 16(2):106–112.
Article
3. Hong JY, Choue R. The effects of vitamin K supplements on serum osteocalcin carboxylation in postmenopausal women. Korean J Nutr. 1999. 32(6):726–731.
4. Kalkwarf HJ, Khoury JC, Bean J, Elliot JG. Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr. 2004. 80(4):1075–1080.
Article
5. Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, Dawson-Hughes B, Wilson PW, Cupples LA, Kiel DP. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr. 2003. 77(2):512–516.
Article
6. Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F. Serum vitamin K level and bone mineral density in post-menopausal women. Int J Gynaecol Obstet. 1997. 56(1):25–30.
Article
7. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K
2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000. 15(3):515–521.
Article
8. Iwamoto I, Kosha S, Noguchi S, Murakami M, Fujino T, Douchi T, Nagata Y. A longitudinal study of the effect of vitamin K
2 on bone mineral density in postmenopausal women a comparative study with vitamin D
3 and estrogen-progestin therapy. Maturitas. 1999. 31(2):161–164.
Article
9. Hong JY, Choue R. Correlation of dietary vitamin K intakes and bone mineral density in postmenopausal women. Korean J Nutr. 1997. 30(3):299–306.
10. Iwamoto J, Yeh JK, Takeda T, Ichimura S, Sato Y. Comparative effects of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium-deficient young rats. Bone. 2003. 33(4):557–566.
Article
11. Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res. 1997. 12(3):431–438.
Article
12. Iwamoto J, Takeda T, Ichimura S, Sato Y, Yeh JK. Differential effect of vitamin K and vitamin D supplementation on bone mass in young rats fed normal or low calcium diet. Yonsei Med J. 2004. 45(2):314–324.
Article
13. Iwamoto J, Yeh JK, Takeda T, Sato Y. Effects of vitamin K
2 administration on calcium balance and bone mass in young rats fed normal or low calcium diet. Horm Res. 2005. 63(5):211–219.
Article
14. Hara K, Kobayashi M, Akiyama Y. Vitamin K
2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone. 2002. 31(5):575–581.
Article
15. Binkley N, Krueger D, Engelke J, Crenshaw T, Suttie J. Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats. Bone. 2002. 30(6):897–900.
Article
16. Mawatari T, Miura H, Higaki H, Moro-Oka T, Kurata K, Murakami T, Iwamoto Y. Effect of vitamin K
2 on three-dimensional trabecular microarchitecture in ovariectomized rats. J Bone Miner Res. 2000. 15(9):1810–1817.
Article
17. Akiyama Y, Hara K, Ohkawa I, Tajima T. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn J Pharmacol. 1993. 62(2):145–153.
Article
18. Iwamoto J, Takeda T, Yeh JK, Ichimura S, Toyama Y. Effect of vitamin K
2 on cortical and cancellous bones in orchidectomized young rats. Maturitas. 2003. 44(1):19–27.
Article
19. Onodera K, Takahashi A, Sakurada S, Okano Y. Effects of phenytoin and/or vitamin K
2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sci. 2002. 70(13):1533–1542.
Article
20. Mitruka BM, Rawnsley HM. Clinical biochemical and hematological reference values in normal experimental animals and normal humans. 1987. 2nd edition. New York: Masson;160.
21. Kobayashi M, Hara K, Akiyama Y. Effects of vitamin K
2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low -magnesium diet. Bone. 2004. 35(5):1136–1143.
Article
22. Douglas AS, Robins SP, Hutchison JD, Porter RW, Stewart A, Reid DM. Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone. 1995. 17(1):15–20.
Article
23. Ushiroyama T, Ikeda A, Ueki M. Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas. 2002. 41(3):211–221.
Article
24. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993. 91(4):1769–1774.
Article
25. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab. 1997. 82(3):719–724.
Article
26. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr. 1998. 68:Suppl. 1358S–1363S.
Article
27. Bunyaratavej N, Penkitti P, Kittimanon N, Boonsangsom P, Bonjongsat A, Yunoi S. Efficacy and safety of Menatetrenone-4 postmenopausal Thai women. J Med Assoc Thai. 2001. 84:Suppl 2. S553–S559.
28. Ozuru R, Sugimoto T, Yamaguchi T, Chihara K. Time-dependent effects of vitamin K
2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J. 2002. 49(3):363–370.
Article
29. Sogabe N, Maruyama R, Baba O, Hosoi T, Goseki-Sone M. Effects of long-term vitamin K(1) (phylloquinone) or vitamin K(2) (menaquinone-4) supplementation on body composition and serum parameters in rats. Bone. 2011. 48(5):1036–1042.
Article
30. Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res. 1997. 12(3):431–438.
Article
31. Peters BS, Martini LA. Nutritional aspects of the prevention and treatment of osteoporosis. Arq Bras Endocrinol Metabol. 2010. 54(2):179–185.
Article